China Resources Double-Crane Pharmaceutical Co. Ltd. A | Ownership
Companies that own China Resources Double-Crane Pharmaceutical Co. Ltd. A
HSBC Jintrust Management Co., Ltd.
57,013,086
6.93%
57,013,086
6.55%
09/30/2017
China Investment Corp. (Investment Management)
17,780,256
2.16%
0
0.12%
09/30/2017
Zhong Ou Asset Management Co., Ltd
13,033,414
1.58%
8,016,153
0.56%
12/31/2017
E Fund Management Co., Ltd.
7,158,316
0.87%
2,536,060
0.12%
09/30/2017
China Life Asset Management Co., Ltd.
6,530,476
0.79%
-6,915,310
0.17%
09/30/2017
Value Partners Ltd.
5,608,279
0.68%
5,608,279
0.2%
12/31/2017
China Universal Asset Management Co., Ltd.
4,698,908
0.56%
2,782,415
0.09%
12/31/2017
Penghua Fund Management Co., Ltd.
3,420,338
0.42%
3,382,034
0.08%
12/31/2017
Harvest Fund Management Co., Ltd.
3,346,659
0.41%
-1,448,714
0.05%
07/27/2018
AXA-SPDB Investment Managers Co., Ltd.
2,971,631
0.36%
-162,960
0.81%
12/31/2017
About China Resources Double-Crane Pharmaceutical Co.
View Profile
| Address |
No. 1 Lize East 2nd Road
Beijing Beijing 100102
China
|
|
Employees
|
- |
| Website |
http://www.dcpc.com |
| Updated |
07/08/2019 |
| China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the drug development, manufacturing, and sale. It focuses on injection, cardiovascular and cerebrovascular, endocrinology, and pediatric field. It specializes in slow disease general medicine business, specialist business, and infusion business. |
